The SME Office has published its annual report summarising its experience with small and medium-sized enterprises (SMEs) during the year 2018.
SMEs represent 99% of all businesses in the European Union and in the pharmaceutical sector they are a motor of innovation.
To support SMEs throughout all stages of medicines’ development, the European Medicines Agency (EMA) established the SME Office in December 2005. The SME Office provides active regulatory, procedural and administrative support to registered SMEs.
To apply for SME status, companies have to fill out the electronic declaration form ‘Declaration on the qualification of an enterprise as micro-, small or medium-sized enterprise (SME)’ and submit it to the SME Office.